Final NHS nod for Allergan’s Ozurdex, AbbVie’s Humira in uveitis
admin 27th July 2017 Uncategorised 0Cost regulators for NHS treatments in England and Wales have deemed AbbVie’s Humira and Allergan’s Ozurdex clinically and cost effective for treating adults with certain types of non-infectious uveitis who have had an inadequate response to corticosteroids.
More: Final NHS nod for Allergan’s Ozurdex, AbbVie’s Humira in uveitis
Source: News